Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded May 21, 2025 · Filed May 23, 2025
The CEO of Phio Pharmaceuticals paid $5.3K out of pocket for Phio Pharmaceuticals shares. 1 other person at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 15% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$5,310
Shares × reported transaction price
<$25K
+15.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 1.4% of the CEO's reported total pay for fiscal 2024 ($387K)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-08-14. The proxy does not tag the CEO's name, so the match rests on the Form 4 title only. A size comparison, not a judgement
6 days after results of May 15, 2025, 85 days before results of Aug 14, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +22.2% | +0.8% | +21.4% |
| 30 days | +29.2% | +3.5% | +25.7% |
| 90 days | +16.4% | +8.7% | +7.7% |
| 180 days | −32.2% | +13.1% | −45.3% |
| 365 days | −35.7% | +26.9% | −62.6% |
Past results only. Not a forecast.
Insider buying
Traded Jun 10, 2025 · filed 1 day later
A Phio Pharmaceuticals director paid $6K out of pocket for Phio Pharmaceuticals shares. 1 other person at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 19% with this purchase.
Insider buying
Traded Jun 10, 2025 · filed 1 day later
The CEO of Phio Pharmaceuticals paid $4.8K out of pocket for Phio Pharmaceuticals shares. 1 other person at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 8% with this purchase.
Insider buying
Traded Jun 9, 2025 · filed 1 day later
The CEO of Phio Pharmaceuticals paid $4.1K out of pocket for Phio Pharmaceuticals shares. 1 other person at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 6% with this purchase.
Robert J Bitterman, Chairman, Pres & CEO's past purchases, 90 days after disclosure: 8 buys, median −5.8 pts vs S&P 500, beat it 3 of 8 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.